| |
| |
|
| Insider
Information: |
Kosaraju Sridhar |
| Relationship: |
|
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
141,699 |
|
|
Indirect Shares
|
158,351 |
|
|
| Direct
Value |
$13,918,316 |
|
|
|
Indirect Value
|
$29,434,354 |
|
|
| Total
Shares |
300,050 |
|
|
| Total
Value |
$43,352,670 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penumbra Inc |
PEN |
President |
2019-04-29 |
71,601 |
2020-04-15 |
155,351 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
32,443 |
2023-06-14 |
3,000 |
Premium* |
|
|
Nevro Corp |
NVRO |
|
2024-05-23 |
37,655 |
2021-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-07-23 |
4 |
AS |
$182.32 |
$275,500 |
I/I |
(1,500) |
10,500 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-08-23 |
4 |
AS |
$157.72 |
$243,088 |
I/I |
(1,500) |
9,000 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,459 |
2,459 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-09-23 |
4 |
AS |
$157.71 |
$238,562 |
I/I |
(1,500) |
7,500 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-10-25 |
4 |
AS |
$163.85 |
$249,478 |
I/I |
(1,500) |
6,000 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-11-24 |
4 |
AS |
$150.06 |
$225,084 |
I/I |
(1,500) |
4,500 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-12-30 |
4 |
AS |
$150.38 |
$225,569 |
I/I |
(1,500) |
3,000 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2021-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
169 |
2,628 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
190 |
2,818 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2022-05-16 |
4 |
OE |
$11.48 |
$172,200 |
D/D |
15,000 |
18,458 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,155 |
6,973 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,120 |
20,578 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
331 |
7,304 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2022-09-14 |
4 |
OE |
$11.48 |
$114,800 |
D/D |
10,000 |
30,578 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
337 |
7,641 |
0 |
- |
|
| NVRO |
Nevro Corp |
Director |
– • – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
397 |
8,038 |
0 |
- |
|
| PEN |
Penumbra Inc |
President |
• – – |
2020-01-30 |
4 |
AS |
$175.09 |
$440,373 |
I/I |
(2,500) |
163,851 |
0 |
% |
|
| PEN |
Penumbra Inc |
President |
• – – |
2020-02-18 |
4 |
AS |
$189.93 |
$476,761 |
I/I |
(2,500) |
160,351 |
0 |
% |
|
| PEN |
Penumbra Inc |
President |
• – – |
2020-03-16 |
4 |
AS |
$150.00 |
$385,901 |
I/I |
(2,500) |
157,851 |
0 |
% |
|
| PEN |
Penumbra Inc |
President |
• – – |
2020-04-15 |
4 |
AS |
$164.89 |
$423,204 |
I/I |
(2,500) |
155,351 |
0 |
% |
|
70 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
